Difficulty: Medium
Average Score: 92%
Practice
A 10-year-old child has intermittent symptoms of mild asthma... Which treatment option is most appropriate?
Correct answer
D
Rationale
The most appropriate treatment option for a 10-year-old child with intermittent mild asthma symptoms is option D, which is the inhaled ╬▓Ôéé-agonist as needed for symptoms. In pediatric asthma management, inhaled ╬▓Ôéé-agonists are considered first-line rescue medications for relieving acute asthma symptoms by quickly dilating the airways and improving airflow. These medications are fast-acting and provide immediate relief during asthma exacerbations.
Option A, environmental control and patient education only without medication, is not the most appropriate choice for a child with mild asthma symptoms. While environmental control and patient education are essential components of asthma management, medication is often necessary to provide prompt relief during asthma attacks.
Option B, oral theophylline, is not the preferred treatment for mild intermittent asthma in children due to its narrow therapeutic window, potential for toxicity, and the availability of safer and more effective medications, such as inhaled bronchodilators.
Option C, cromolyn, is a mast cell stabilizer that is used more for prevention of asthma symptoms rather than for quick relief during acute exacerbations. Inhaled ╬▓Ôéé-agonists are more suitable for providing immediate relief of bronchoconstriction in a child experiencing intermittent mild asthma symptoms.
In an educational context, it is crucial for pediatric clinical nurse specialists to have a solid understanding of asthma management in children. By choosing the appropriate medication based on the severity of symptoms and individual patient needs, healthcare providers can effectively control asthma and improve the quality of life for pediatric patients with asthma. Understanding the rationale behind each treatment option helps healthcare professionals make informed decisions and provide optimal care for pediatric patients with asthma.
Option A, environmental control and patient education only without medication, is not the most appropriate choice for a child with mild asthma symptoms. While environmental control and patient education are essential components of asthma management, medication is often necessary to provide prompt relief during asthma attacks.
Option B, oral theophylline, is not the preferred treatment for mild intermittent asthma in children due to its narrow therapeutic window, potential for toxicity, and the availability of safer and more effective medications, such as inhaled bronchodilators.
Option C, cromolyn, is a mast cell stabilizer that is used more for prevention of asthma symptoms rather than for quick relief during acute exacerbations. Inhaled ╬▓Ôéé-agonists are more suitable for providing immediate relief of bronchoconstriction in a child experiencing intermittent mild asthma symptoms.
In an educational context, it is crucial for pediatric clinical nurse specialists to have a solid understanding of asthma management in children. By choosing the appropriate medication based on the severity of symptoms and individual patient needs, healthcare providers can effectively control asthma and improve the quality of life for pediatric patients with asthma. Understanding the rationale behind each treatment option helps healthcare professionals make informed decisions and provide optimal care for pediatric patients with asthma.